$2B Steris Inversion Could Be Delayed By Deeper FTC Probe
Plans to unite medical technology company Steris Corp. with Synergy Health PLC hit a snag on Monday when the Federal Trade Commission deepened its review of the $1.9 billion deal, the...To view the full article, register now.
Already a subscriber? Click here to view full article